Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2650 of 3284 entries
View as:

A Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-ocular Pressure

Phase: N/A Priority: Normal
NCT ID: NCT01173471 Org: User:
Start: 12/31/10 End: 11/30/12 Due: 11/30/13

Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination

Phase: N/A Priority: Normal
NCT ID: NCT00044668 Org: User:
Start: 08/31/02 End: 09/30/05 Due: 09/30/06

A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 Mutations

Phase: N/A Priority: Normal
NCT ID: NCT05048797 Org: User:
Start: 10/28/21 End: 07/30/27 Due: 07/30/28

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00035984 Org: User:
Start: 05/31/02 End: 08/31/03 Due: 08/31/04

A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT05397171 Org: User:
Start: 06/07/22 End: 06/06/23 Due: 06/06/24

A Study to Investigate the Biological Effects of Saruparib (AZD5305), Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT05938270 Org: User:
Start: 09/21/23 End: 11/14/25 Due: 11/14/26

Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study

Phase: N/A Priority: Normal
NCT ID: NCT05665374 Org: User:
Start: 06/19/23 End: 05/11/26 Due: 05/11/27

A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure

Phase: N/A Priority: Normal
NCT ID: NCT06692764 Org: User:
Start: 10/30/24 End: 05/02/25 Due: 05/02/26

Technology-Assisted Cholesterol Trial in Consumers (TACTiC)

Phase: N/A Priority: Normal
NCT ID: NCT04964544 Org: User:
Start: 07/08/21 End: 03/01/23 Due: 03/01/24

A Phase I Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD5004

Phase: N/A Priority: Normal
NCT ID: NCT06742762 Org: User:
Start: 12/17/24 End: 04/20/25 Due: 04/20/26

Olaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03534453 Org: User:
Start: 05/29/18 End: 12/31/24 Due: 12/31/25

A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT06245551 Org: User:
Start: 12/22/23 End: 06/29/24 Due: 06/29/25

Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03788746 Org: User:
Start: 01/17/19 End: 05/25/23 Due: 05/25/24

Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT06531798 Org: User:
Start: 07/30/25 End: 07/30/27 Due: 07/30/28

Retrospective Observational Study DIANA Study

Phase: N/A Priority: Normal
NCT ID: NCT01976793 Org: User:
Start: 12/31/13 End: 12/31/13 Due: 12/31/14

Study of Ticilimumab in Patients With Metastatic Colorectal Cancer Whose Disease Had Progressed After Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00313794 Org: User:
Start: 05/31/06 End: 06/30/08 Due: 06/30/09

ATAC - Arimidex, Tamoxifen Alone or in Combination

Phase: N/A Priority: Normal
NCT ID: NCT00849030 Org: User:
Start: 07/31/96 End: 04/30/10 Due: 04/30/11

Chinese Multiple Dose Escalation (MDE) High Dose Study

Phase: N/A Priority: Normal
NCT ID: NCT05437848 Org: User:
Start: 02/25/22 End: 12/12/22 Due: 12/12/23

An Open-label, Phase II Study of AZD4635 in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04089553 Org: User:
Start: 08/29/19 End: 04/11/23 Due: 04/11/24

Estimation of the Prevalence of HER2 Low and Describe the SoC, Treatment Patterns, and Outcome in Real-world Practice Among Unresectable and/or Metastatic Breast Cancer Patients With HER2 Low Status

Phase: N/A Priority: Normal
NCT ID: NCT04807595 Org: User:
Start: 05/28/21 End: 04/26/22 Due: 04/26/23

Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US

Phase: N/A Priority: Normal
NCT ID: NCT00660660 Org: User:
Start: 04/30/08 End: 07/31/08 Due: 07/31/09

An Open-label, Randomized, Crossover Study of Comparative Pharmacokinetics and Bioequivalence of Dapagliflozin + Metformin, 10 mg + 1000 mg Versus the Combined Use of Forxiga™, 10 mg and Two Glucophage® Long, ER Tablets, 500 mg Co-administered to Healthy Volunteers Under Standard Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02722239 Org: User:
Start: 03/30/16 End: 05/05/16 Due: 05/05/17

Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Heart Disease Death

Phase: N/A Priority: Normal
NCT ID: NCT01360073 Org: User:
Start: 07/31/11 End: 12/31/11 Due: 12/31/12

Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.

Phase: N/A Priority: Normal
NCT ID: NCT04346199 Org: User:
Start: 06/12/20 End: 11/17/20 Due: 11/17/21

Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease

Phase: N/A Priority: Normal
NCT ID: NCT06851806 Org: User:
Start: 06/02/25 End: 06/30/26 Due: 06/30/27